121 results on '"T. Hawighorst"'
Search Results
52. A dual-aptamer-based biosensor for specific detection of breast cancer biomarker HER2 via flower-like nanozymes and DNA nanostructures.
53. Insights into Islet Differentiation and Maturation through Proteomic Characterization of a Human iPSC‐Derived Pancreatic Endocrine Model.
54. Ultrasensitive enzyme-free fluorescent detection of VEGF165 based on target-triggered hybridization chain reaction amplification.
55. Self-assembly of peptide amphiphiles for drug delivery: the role of peptide primary and secondary structures.
56. Platelet-Rich Plasma as an Autologous and Proangiogenic Cell Delivery System.
57. Detection of early pancreatic ductal adenocarcinoma with thrombospondin-2 and CA19-9 blood markers.
58. Zinc Oxide Nanorod-Based Piezoelectric Dermal Patch for Wound Healing.
59. Emerging nanomedicine approaches fighting tumor metastasis: animal models, metastasis-targeted drug delivery, phototherapy, and immunotherapy.
60. Microneedles for the Noninvasive Structural and Functional Assessment of Dermal Lymphatic Vessels.
61. Interstitial flows promote amoeboid over mesenchymal motility of breast cancer cells revealed by a three dimensional microfluidic model.
62. Multimodal Nanoparticle for Primary Tumor Delineation and Lymphatic Metastasis Mapping in a Head-and-Neck Cancer Rabbit Model.
63. Magnetic Field-Enhanced Photothermal Ablation of Tumor Sentinel Lymph Nodes to Inhibit Cancer Metastasis.
64. Development of individualized anti-metastasis strategies by engineering nanomedicines.
65. Imaging-Guided Combined Photothermal and Radiotherapy to Treat Subcutaneous and Metastatic Tumors Using Iodine-131-Doped Copper Sulfide Nanoparticles.
66. Microfluidic isolation of cancer-cell-derived microvesicles from hetergeneous extracellular shed vesicle populations.
67. Vasculogenesis.
68. Eye Development.
69. Tumor Metastasis Inhibition by Imaging-Guided Photothermal Therapy with Single-Walled Carbon Nanotubes.
70. Lymphatics and Lymphangiogenesis in the Eye.
71. Vascular Complications and Diabetes: Current Therapies and Future Challenges.
72. Agonists and antagonists of GnRH-I and -II reduce metastasis formation by triple-negative human breast cancer cells in vivo.
73. Adipositas - Risikofaktor für onkologische Erkrankungen.
74. CD36-mediated activation of endothelial cell apoptosis by an N-terminal recombinant fragment of thrombospondin-2 inhibits breast cancer growth and metastasis in vivo.
75. Biomechanical Forces Shape the Tumor Microenvironment.
76. Combined Effects of Surface Morphology and Mechanical Straining Magnitudes on the Differentiation of Mesenchymal Stem Cells without Using Biochemical Reagents.
77. Lymphangiogenesis and Axillary Lymph NodeMetastases Correlated with VEGF-C Expression in Two Immunocompetent MouseMammary CarcinomaModels.
78. Tumorstammzellen in Mamma- und weiblichen Genitalkarzinomen.
79. Angiogenese in Reproduktionsmedizin und gynäkologischer Onkologie.
80. Stimulation of functional vessel growth by gene therapy.
81. Angiogenesis and Lymphangiogenesis of Gastric Cancer.
82. Systemtherapie beim Endometriumkarzinom.
83. Moderne Konzepte in der Behandlung des Endometriumkarzinoms.
84. Dauertokolyse mit β2-Sympathikomimetika – Retrospektive Analyse an einem Zentrum.
85. Differenzielle Analyse von Blut-versus Lymphgefäßen in gynäkologischen Tumoren.
86. Hemmung der Karzinogenese durch transgene Überexpression von Thrombospondin-2.
87. Peptide Targeting of Tumor Lymph Vessels.
88. Die operative Behandlung von schweren atonischen Nachblutungen mit Uterus-Kompressionsn�hten in Anlehnung an Pereira.
89. Proteomic Analysis of Exosomes Isolated from Human Malignant Pleural Effusions.
90. Angiogenesis with biomaterial-based drug- and cell-delivery systems.
91. Endokrine Therapie des Endometriumkarzinoms und seiner Präkanzerosen.
92. Role of IGF-1R in Mediating Breast Cancer Invasion and Metastasis.
93. Traceless Solid-Phase Synthesis of 2-Aminothiazoles: Receptor Tyrosine Kinase Inhibitors with Dual Selectivity for Tie-2 and VEGFR-2.
94. Thrombospondin-1 selectively inhibits early-stage carcinogenesis and angiogenesis but not tumor lymphangiogenesis and lymphatic metastasis in trasgenic mice.
95. A phase I/II trial of rAd/p53 (SCH 58500) gene replacement in recurrent ovarian cancer.
96. Role of Vascular Endothelial Growth Factor during Breast Cancer.
97. Natural Product Derived Receptor Tyrosine Kinase Inhibitors: Identification of IGF1R, Tie-2, and VEGFR-3 Inhibitors.
98. Mikroinvasive laparoskopische Cholecystektomie mit 2-mm-Instrumenten Methodenvorstellung und erste Ergebnisse.
99. Gynäkologische Onkologie.
100. 52. Kongreß der Deutschen Gesellschaft für Gynäkologie und Geburtshilfe Nürnberg, 8.–12. September 1998.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.